Alvogen Pharma US, Inc. Alvogen Pharma US, Inc., Loan (Second Lien) - Second Lien is a security (CUSIP 02255HAF7) tracked across SEC portfolio filings. 1 registered fund positions totaling $1.7M via N-PORT as of 2026-03-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| First Eagle Credit Opportunities Fund | First Eagle Credit Opportunities Fund | $1.7M | 23.64% |